Rush University Medical Center
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Rush University Medical Center sits in the top decile of US sponsors by registered trial count (#112 of 15,742 sponsors by registered trial count).
Rush University Medical Center: 320 sponsored US clinical trials, 53 recruiting.
Rush University Medical Center sponsors 320 registered US clinical trials on ClinicalTrials.gov, 53 of them currently recruiting, and 206 completed. 42 of these trials are in Phase 3-4 (later-stage) and 41 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Total Knee Arthroplasty, with 3 trials.
Top-decile sponsor footprint
Rush University Medical Center ranks in the top decile of sponsors by registered trial count (#112 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
206 of 244 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
320 total, page 7 of 7
Telephone Resources and Assistance for Caregivers (TRAC)
NCT00721383
A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
NCT00479167
Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS
NCT00467610
Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer
NCT00597597
Engaging Low-Income Families in Prevention Programs
NCT01405404
Dietary Treatment of Crohn's Disease
NCT00343642
Study Comparing Mini-Incision Versus 2-Incision Approach for Total Hip Replacement
NCT00594893
Improve Speech Using an In-the-ear Device in Parkinson's Disease
NCT00488657
Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With IV Insulin
NCT00795015
Preliminary Study of Safety and Efficacy of Policosanol
NCT00312923
Treatment of Depression With Quetiapine
NCT00174603
MATCH: The Mexican-American Trial of Community Health Workers
NCT01067092
Simplified Diagnostic Algorithm for Evaluation of Neonates With Prenatally Detected Hydronephrosis
NCT01330511
Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA
NCT00920725
A Randomized Study on Comparing the Efficacy of Foley Catheter and Extraamniotic Saline Infusion for Labor Induction
NCT00366951
A Study of Orthotic Shoe Inserts for Controlling Osteoarthritic Knee Pain
NCT00076453
Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock
NCT00604019
Alcohol, Gut Leakiness, & Liver Disease
NCT05428072
Treatment of Major Depressive Disorder With Psychotic Features.
NCT00174590
Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
NCT00014443
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 16 |
| Phase 2 | 25 |
| Phase 3 | 6 |
| Phase 4 | 36 |
Therapeutic Areas
What is open in the Rush University Medical Center pipeline
53 recruiting of 320 indexed (17% open); 206 completed (64%).
Phase mix: 42 late (III/IV) vs 41 early (I/II) (balanced across stages).
Top condition: Total Knee Arthroplasty (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rush University Medical Center: open-pipeline peers nationwide
Peers matched on 320 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Rush University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 320 trials (± recruiting share)
- Jonsson Comprehensive Cancer Center · 321 trials · 19% recruiting
- University of Arkansas · 318 trials · 12% recruiting
- Allergan · 314 trials · 0% recruiting
- Genentech · 332 trials · 7% recruiting
Sponsors near 17% open enrollment (± trial volume)
- OHSU Knight Cancer Institute · 17% recruiting · 211 trials
- Massachusetts General Hospital · 17% recruiting · 2,032 trials
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
Related
What to do with this Rush University Medical Center page
320 registered trials is a research-attention snapshot, not an endorsement of Rush University Medical Center or any single study.
- 53 of Rush University Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Total Knee Arthroplasty is the condition Rush University Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Total Knee Arthroplasty trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Rush University Medical Center pipeline card: 320 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.